FDA Import Refusal SCS-3440627-3/11/9 — Glaxosmithkline
The FDA refused shipment SCS-3440627-3/11/9 from Glaxosmithkline (France) on Feb 21, 2019. The refused product falls under Drugs and Biologics — ALBENDAZOLE (ANTHELMINTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 21, 2019
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 60WCA01 ALBENDAZOLE (ANTHELMINTIC)
- Charges
- 75